These 7 companies have received the most funding for anti-aging research

The promise of companies that can somehow delay the inevitable — aging — is fueling increased investment in biotech businesses that directly target human longevity or individual age-related diseases. In 2017, $559.4 million in venture capital was invested in U.S. anti-aging companies —158 percent more than five years ago, according to data from Pitchbook, which tracks VC funding. Many of these anti-aging companies and investors are located in the Bay Area. Here’s a look at the most funded…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news